Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance

Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

August 7, 2023 4:15 PM EDT

Revenue of $207.9 million, up 83% year-over-year in Q2 2023

Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023

Subscribers grew to 1.3 million, up 74% year-over-year in Q2 2023

Raises full year 2023 revenue guidance to a range of $830 million to $850 million and Adjusted EBITDA guidance to a range of $35 million to $40 million

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the second quarter... More